Original Article

Assessment of seroprevalence of Toxoplasma gondii in blood donors applied to the blood center of Gazi university hospital

Abstract

Background and Objectives: Toxoplasmosis is a life threatening zoonotic infection in immunosuppressive individuals. The risk of transmission of toxoplasmosis through the blood donors isseverely high. Determining the prevalence and seropositivity rates of toxoplasmosis inasymptomatic blood donors is crucial in terms of the risk status of the transmission ofthis infection to the blood recipients.

Materials and Methods: In this study, the presence and level of the specific Toxoplasma IgG and IgM antibodies in donors' blood is investigated by
electrochemiluminescence immunoassay (ECLIA). The statistical significance levels between Toxoplasma seropositivity and demographic characteristics of the donors such as age, educational status, raw meat consumption, drinking water supply are examined.

Results: Toxoplasma IgG seropositivity is found among the 225 (25.6%) of the donors present inthe study group, while IgM seropositivity is detected in 20 donors (2.3%). Both IgG and IgM seropositivities are found in 12 donors (1.4%).

Conclusion: Our study provides information about Toxoplasma seropositivity based on the samples collected from the donors who were admitted to the blood centre of a university hospital in Ankara, Turkey. This study, demonstrates that Toxoplasma seropositivity is high in the rural areas and the regions where the education level is low.

1. Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Tropical Biomedicine. 2019;36: 898-925.
2. Malatyalı E, Yıldız İ, Tileklioğlu E, Ertabaklar H, Ertuğ S. Retrospective Analysis of Toxoplasma gondii Serology Results from Adnan Menderes University Faculty of Medicine Parasitology Laboratory from 2007 to 2017. Turkiye Parazitoloji Derg. 2019;43:1–4.
3. Chemoh W, Nur Farhana MN, Noor Azmi MA, Si Lay K, Sawangjaroen N, Tan TC, et al. Prevalence and risk factors of Toxoplasma infection – an update in Malaysian pregnant women. Trop Biomed. 2019;36:694-702.
4. Saki J, Foroutan M, Khodkar I, Khodadadi A, Nazari L. Seroprevalence and molecular detection of Toxoplasma gondii in healthy blood donors in southwest Iran. Transfus. Apher. Sci. 2019;58:79–82.
5. Nakashima F, Pardo VS, Miola MP, Murata FHA, Paduan N, Longo SM, et al. Serum IgG Anti-Toxoplasma gondii Antibody Concentrations Do Not Correlate Nested PCR Results in Blood Donors. Front Cell Infect Microbiol. 2020;9:1–6.
6. Mustafa M, Fathy F, Mirghani A, Mohamed MA, Muneer MS, Ahmed AE, et al. Prevalence and risk factors profile of seropositive Toxoplasma gondii infection among apparently immunocompetent Sudanese women. BMC Res Notes. 2019;12:1–6.
7. Ref C, Rinle KP, King E, Nelson A, Saidu AJ, Tobias C, et al. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United 1 States and implications for developing countries. Plos Neglected Tropical Diseases. 2017;11: e0005670
8. Çökmez H., Aydın Ç. Seroprevalence of Toxoplasma antibody in pregnant women: Should we screen? Ortadogu Medical Journal. 2019; 11: 415-421.
9. Sert UY, Ozgu-Erdinc AS, Gokay S, Engin-Ustun Y. Toxoplasma Screening Results of 84587 Pregnant Women in a Tertiary Referral Center in Turkey. Fetal Pediatr Pathol. 2019;38:307–16.
10. Achaw B, Tesfa H, Zeleke AJ, Worku L, Addisu A, Yigzaw N, et al. Sero-prevalence of Toxoplasma gondii and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia. BMC Infect Dis. 2019;19:1–8.
11. Ramírez AM, Ríos YK, Galvis NF, Entrena E, Mariño NV, Rangel DM, et al. Seroprevalencia y detección molecular de Toxoplasma gondii en donantes de un banço de sangre de Cúcuta, Colombia. Biomedica. 2019;39:144–56.
12. Ercan NE, Kirmizigül AH. Prevalance of Toxoplasma gondii indoor cats in Kars. Ataturk Univ. Vet. Bilim Derg. 2019;14:23–8.
13. Rehman F, Shah M, Ali A, Ahmad I, Sarwar MT, Rapisarda AMC, et al. Unpasteurised milk consumption as a potential risk factor for toxoplasmosis in females with recurrent pregnancy loss. J Obstet Gynaecol. 2020;0:1–5.
14. Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, de Wit LA, VanWormer E, et al. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 2019;15.
15. Simon JA, Kurdzielewicz S, Jeanniot E, Dupuis E, Marnef F, Aubert D, et al. Spatial distribution of soil contaminated with Toxoplasma gondii oocysts in relation to the distribution and use of domestic cat defecation sites on dairy farms. Int J Parasitol. 2017;47:357–67.
16. Alver O, Payaslıoğlu M, Ener B. Investigation of Toxoplasma gondii Seropositivity in Uludağ University Hospital between 2009-2016. Turkiye Parazitolojii Derg. 2019;43:8–12.
Files
IssueVol 13 No 2 (2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v13i2.5986
Keywords
toxoplasmosis prevalence antibody transfusion medicine
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Yılmaz A, Yazıcı E, Türk C. Assessment of seroprevalence of Toxoplasma gondii in blood donors applied to the blood center of Gazi university hospital. Iran J Microbiol. 2021;13(2):243-247.